Press release
Cerbomed GmbH at the 11th European Congress on Epileptology in Stockholm
About t-VNS with NEMOS
Transcutaneous Vagus Nerve Stimulation with NEMOS offers a further therapy option to epilepsy patients, who suffer from continued occurrence of seizures, despite appropriate treatment with anticonvulsive drugs.
The t-VNS therapy uses the fact that a branch of the vagus nerve is located directly under the skin in areas of the outer ear and therefore can be stimulated through the skin (transcutaneously) with electrical impulses.
The treatment with NEMOS is carried out autonomously by the patients by using the therapy device NEMOS, a special stimulator and a dedicated ear electrode, that sends out the electrical impulses. With NEMOS a targeted stimulation of the vagus nerve gets possible without the need of a surgery.
About cerbomed
Cerbomed GmbH is an innovative medical device company located in Erlangen, Germany, that focuses on neuromodulation. The company, founded in 2005, focuses on transcutaneous Vagus Nerve Stimulation (t-VNS), which may offer an attractive therapy option for patients with hard-to-treat neurological and psychiatric illnesses.
The transcutaneous Vagus Nerve Stimulation received the European clearance (CE mark) for the treatment of epilepsies, depression and pain. Currently two clinical studies are carried out regarding the effectiveness of t-VNS in patients with drug-resistant epilepsy and chronic migraine.
In September 2012 cerbomed entered into a strategic partnership with Cyberonics, Inc., the global market leader in vagus nerve stimulation.
The therapy device NEMOS is available for treating epilepsies in Germany, Austria, Switzerland and Italy.
Please visit us on www.cerbomed.com.
cerbomed GmbH
Dr. Martin Hyca, Director Marketing & Sales
Henkestrasse 91
DE-91052 Erlangen
+49 9131 9202 76 30
martin.hyca@cerbomed.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cerbomed GmbH at the 11th European Congress on Epileptology in Stockholm here
News-ID: 290755 • Views: …
More Releases from cerbomed GmbH
Pharmaceuticals and medical technology will go hand in hand in future – DESITI …
ERLANGEN/HAMBURG, September 17th, 2015 – The medical technology company cerbomed GmbH from Erlangen and the pharmaceutical company DESITIN Arzneimittel GmbH from Hamburg have entered into a groundbreaking distribution agreement: DESITIN has been granted exclusive distribution rights in Germany by cerbomed for the transcutaneous vagus nerve stimulator NEMOS for treatment of epilepsy.
The successful medium-sized independent company DESITIN has been a specialist provider and proficient partner to doctors and patients in the…
transcutaneous Vagus Nerve Stimulation for epilepsies now available in Norway
ERLANGEN/DRAMMEN, May 28th, 2015 – To address the Norwegian market with transcutaneous Vagus Nerve Stimulation (t-VNS), the medical device company cerbomed from Erlangen, Germany, is cooperating with an experienced distribution partner: Scan-Med A/S from Drammen, Norway.
The company, founded in 1982, considers itself as a connecting link between manufacturers of medical devices and hospitals, as well as health institutions and specialized on distribution service and support of medical equipment.
“We are…
Vagus nerve stimulation without surgery now available in Denmark, Finland and Sw …
ERLANGEN/AALBORG, Mai 28th, 2015 – More than 30 percent of all epilepsy patients still suffer from continued occurrence of seizures, despite appropriate treatment with anticonvulsive drugs. For these patients, only few treatment alternatives are available at the moment. One promising therapy option is transcutaneous Vagus Nerve Stimulation (t-VNS), now also available for patients in Denmark, Sweden and Finland. This has been made possible by cerbomed‘s new distributor Cephalon A/S.…
Trial results for transcutaneous Vagus Nerve Stimulation in pharmacoresistant ep …
ERLANGEN/DRESDEN, 30th April 2015 – At the 9th annual joint conference of the three German-speaking regions of the International League Against Epilepsy in Dresden, the results of a trial on transcutaneous Vagus Nerve Stimulation (t-VNS) in pharmacoresistant epilepsy were presented for the first time.
Trial shows reduction in seizures with t-VNS
In the multi-centre, randomised, controlled, 2-arm, double-blind study, 76 adult epilepsy patients from Germany and Austria were treated over 5…
More Releases for NEMOS
Wave Energy Market 2022 Top Key Vendors AMOG CONSULTING, AWS Ocean Energy, Carn …
Wave Energy Market Research study 2022-2028 enhances the decision making capabilities and helps to create potent counter strategies to obtain competitive advantage says a latest research report at The Insight Partners. The Wave Energy Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status
Get Sample PDF Now: https://www.theinsightpartners.com/sample/TIPRE00012001/?utm_source=OpenPR&utm_medium=10503
The energy generated by the up and down movement of ocean waves is known…
Wave Energy Market May Set a New Epic Growth Story | Nemos, Carnegie Clean Energ …
The Latest Released Wave Energy market study has evaluated the future growth potential of Global Wave Energy market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers,…
Wave Energy Market Changing Strategies to Provide Competitive Edge 2031 | Nemos, …
Latest update report on Wave Energy Market Size, Share, Growth, Industry Trends and Forecast by 2028. This report is highly predictive as it holds the overall market analysis of the topmost companies into the Wave Energy industry. With the classified Wave Energy market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share and so on. The Market research report on Wave…
Wave Energy Market Outlook with Thrilling Growth by Key Players NEMOS GmbH, Ocea …
This research report will give you deep insights about the Wave Energy Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports are usually purchased across industries by Executives, Managers, Senior Managers, Strategy people, Directors, Vice Presidents, CXOs, etc. and help them in understanding about the market trends and analysis, competition, industry landscape, market…
Wave Energy Market: Year 2020-2027 and its detail analysis by focusing on top ke …
The research report provides a big picture on "Wave Energy market" 2027, on a global basis, offering a forecast and statistic in terms of revenue during the forecast period. This report covers detailed segmentation, complete R & D history, and explanatory analysis including the latest news. Furthermore, the study explains the future opportunities and a sketch of key players involved in the "Wave Energy hike in terms of revenue.
Get sample…
A renewed web presence for cerbomed GmbH
ERLANGEN, Germany, March 8th, 2012 – The German medical device company cerbomed GmbH is re-launching its web site. At www.cerbomed.com patients and their families, as well as doctors, and medical specialists can access tailored information on transcutaneous Vagus Nerve Stimulation (t-VNS), using the device NEMOS. The new therapy alternative for difficult-to-treat epilepsies and depression will be available in Germany in summer 2012.
The new web-presence marks cerbomed as a provider of…
